Header Logo

Connection

Mohammed Rassool to Hepatitis C

Back to Details
This is a "connection" page, showing publications Mohammed Rassool has written about Hepatitis C.
Mohammed Rassool
Connection Strength
0,035
Hepatitis C
  1. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. Lancet HIV. 2017 11; 4(11):e486-e494.
    View in: PubMed
    Score: 0,035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.